Comparing the current results to its competitors, Electrocore Inc reported Revenue increase in the 1 quarter 2026 by 39.64 % year on year. The sales growth was above Electrocore Inc 's competitors' average revenue growth of 18.97 %, achieved in the same quarter.
Strong sales growth of 39.64 % in Overall company contributed to Electrocore Inc increase in total revenue by 39.64 % Electrocore Inc improved its market share in this segment, to approximately 0 %.
Neuropace Inc's business model revolves around the development and commercialization of medical devices for the treatment of neurological disorders, primarily focusing on epilepsy.
Neuroone Medical Technologies Corp Share Performance
-66.35%
This Year
Neuroone Medical Technologies Corp
Profile
Neuroone Medical Technologies Corp operates using a specific business model that focuses on delivering medical solutions or technologies related to neurological disorders or conditions.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Eli Lilly and Company operates as a global pharmaceutical firm that focuses on developing innovative medicines in areas such as diabetes, oncology, and neurodegeneration. Their business model emphasizes research and development, strategic partnerships, and a strong commitment to improving patient outcomes through advanced therapeutics.
Inspire Medical Systems Inc operates on a direct-to-patient business model, focused on developing and commercializing innovative medical devices for patients suffering from sleep apnea. The company's business model revolves around providing a unique therapy solution through the development of its proprietary Inspire therapy system, which includes a surgically implanted device that stimulates the upper airway during sleep. By targeting both physicians and patients, Inspire Medical Systems aims to improve clinical outcomes and bring relief to those with unmet needs in the field of sleep apnea treatment.
Sources:
Electrocore Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Electrocore Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
